EA200400104A1 - Новые производные индола - Google Patents

Новые производные индола

Info

Publication number
EA200400104A1
EA200400104A1 EA200400104A EA200400104A EA200400104A1 EA 200400104 A1 EA200400104 A1 EA 200400104A1 EA 200400104 A EA200400104 A EA 200400104A EA 200400104 A EA200400104 A EA 200400104A EA 200400104 A1 EA200400104 A1 EA 200400104A1
Authority
EA
Eurasian Patent Office
Prior art keywords
disorders
indol derivatives
new indol
new
obsessive
Prior art date
Application number
EA200400104A
Other languages
English (en)
Other versions
EA006104B1 (ru
Inventor
Марио Роттлендер
Айнер Кнуд Молтсен
Иван Миккельсен
Томас Руланд
Ким Андерсен
Кристиан Крог-Енсен
Original Assignee
Х. Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Х. Лундбекк А/С filed Critical Х. Лундбекк А/С
Publication of EA200400104A1 publication Critical patent/EA200400104A1/ru
Publication of EA006104B1 publication Critical patent/EA006104B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Настоящее изобретение относится к гетероарильному производному общей формулы (I)которое полезно для лечения аффективных расстройств, таких как общая тревога, паническое состояние, обсессивно-компульсивное расстройство, депрессия, социальная фобия и расстройства аппетита, а также неврологических расстройств, таких как психоз.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200400104A 2001-06-29 2002-06-27 Производные индола и их применение для лечения психических и неврологических расстройств EA006104B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101037 2001-06-29
PCT/DK2002/000436 WO2003002552A1 (en) 2001-06-29 2002-06-27 Novel indole derivatives

Publications (2)

Publication Number Publication Date
EA200400104A1 true EA200400104A1 (ru) 2004-04-29
EA006104B1 EA006104B1 (ru) 2005-08-25

Family

ID=8160599

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200400104A EA006104B1 (ru) 2001-06-29 2002-06-27 Производные индола и их применение для лечения психических и неврологических расстройств

Country Status (28)

Country Link
US (1) US7342015B2 (ru)
EP (1) EP1399434B1 (ru)
JP (1) JP2004535448A (ru)
KR (1) KR20040019027A (ru)
CN (1) CN100338058C (ru)
AR (1) AR034658A1 (ru)
AT (1) ATE304007T1 (ru)
AU (1) AU2002344950B2 (ru)
BG (1) BG108538A (ru)
BR (1) BR0210407A (ru)
CA (1) CA2451229C (ru)
CZ (1) CZ2004155A3 (ru)
DE (1) DE60206043T2 (ru)
DK (1) DK1399434T3 (ru)
EA (1) EA006104B1 (ru)
ES (1) ES2247347T3 (ru)
HK (1) HK1069579A1 (ru)
HU (1) HUP0400834A2 (ru)
IL (1) IL158830A0 (ru)
IS (1) IS2431B (ru)
MX (1) MXPA03011766A (ru)
NO (1) NO326513B1 (ru)
NZ (1) NZ529461A (ru)
PL (1) PL366520A1 (ru)
SK (1) SK642004A3 (ru)
UA (1) UA74651C2 (ru)
WO (1) WO2003002552A1 (ru)
ZA (1) ZA200308848B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2451228A1 (en) * 2001-06-29 2003-01-09 H. Lundbeck A/S Novel heteroaryl derivatives, their preparation and use
WO2006056600A1 (en) 2004-11-26 2006-06-01 Janssen Pharmaceutica N.V. Isoxazoline-indole derivatives with an improved antipsychotic and anxiolytic a ivity
TWI329641B (en) * 2005-08-31 2010-09-01 Otsuka Pharma Co Ltd (benzo[b]thiophen-4-yl)piperazine compounds, pharmaceutical compositions comprising the same, uses of the same and processes for preparing the same
JP4785881B2 (ja) * 2007-02-27 2011-10-05 大塚製薬株式会社 医薬

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0900792B1 (en) * 1997-09-02 2003-10-29 Duphar International Research B.V Piperazine and piperidine derivatives as 5-HT1A and dopamine D2-receptor (ant)agonists
CN1155567C (zh) * 1998-04-29 2004-06-30 惠氏公司 抑制精神的吲哚基衍生物
AR027134A1 (es) * 1999-12-30 2003-03-12 Lundbeck & Co As H Derivados de indol.
CA2451228A1 (en) 2001-06-29 2003-01-09 H. Lundbeck A/S Novel heteroaryl derivatives, their preparation and use

Also Published As

Publication number Publication date
ZA200308848B (en) 2006-02-22
DE60206043T2 (de) 2006-06-29
CZ2004155A3 (cs) 2004-07-14
UA74651C2 (en) 2006-01-16
WO2003002552A1 (en) 2003-01-09
EA006104B1 (ru) 2005-08-25
JP2004535448A (ja) 2004-11-25
NO20035672D0 (no) 2003-12-18
CN100338058C (zh) 2007-09-19
DK1399434T3 (da) 2005-12-12
EP1399434A1 (en) 2004-03-24
IS7022A (is) 2003-11-10
ES2247347T3 (es) 2006-03-01
US20060258678A1 (en) 2006-11-16
ATE304007T1 (de) 2005-09-15
US7342015B2 (en) 2008-03-11
NO20035672L (no) 2003-12-18
NZ529461A (en) 2005-09-30
HK1069579A1 (en) 2005-05-27
BG108538A (bg) 2005-01-31
IL158830A0 (en) 2004-05-12
CA2451229A1 (en) 2003-01-09
BR0210407A (pt) 2004-08-17
IS2431B (is) 2008-10-15
DE60206043D1 (de) 2005-10-13
AU2002344950B2 (en) 2008-04-03
MXPA03011766A (es) 2004-04-02
KR20040019027A (ko) 2004-03-04
PL366520A1 (en) 2005-02-07
HUP0400834A2 (hu) 2004-08-30
CA2451229C (en) 2009-02-10
EP1399434B1 (en) 2005-09-07
AR034658A1 (es) 2004-03-03
CN1529703A (zh) 2004-09-15
SK642004A3 (en) 2004-05-04
NO326513B1 (no) 2008-12-22

Similar Documents

Publication Publication Date Title
EA200400498A1 (ru) Производные фенилпиперазина как ингибиторы обратного захвата серотонина
EA200500703A1 (ru) Новые трициклические соединения для лечения воспалительных и аллергических нарушений, способ их приготовления и содержащие их фармацевтические составы
SE0303180D0 (sv) Novel compounds
SE0302232D0 (sv) Novel Compounds
EA200301232A1 (ru) Новые соединения арилсульфонамида и их применение для лечения ожирения, диабета типа ii и нарушений центральной нервной системы
SE0201635D0 (sv) Novel compounds
EA200400368A1 (ru) Новые дигидроптеридиноны, способы их получения и их применение в качестве лекарственных средств
EA200400892A1 (ru) Производные никотинамида, полезные в качестве ингибиторов pde4
EA200400006A1 (ru) Бензоилсульфонамиды и сульфонилбензамидины для применения в качестве противоопухолевых агентов
EA200400595A1 (ru) Бензимидазолы, применяемые в качестве ингибиторов протеинкиназы
DE602004016174D1 (de) Substituierte indazolyl(indolyl)maleimid-derivate als kinase inhibitoren
EA200401282A1 (ru) Пиридиноилпиперидины как агонисты 5-ht1f
EA200400586A1 (ru) Замещённые тиоацетамиды
EA200601141A1 (ru) Сульфонамидные производные для лечения заболеваний
CY1108464T1 (el) Παραγωγα 4-(2-φαινυλοσουλφανυλο-φαινυλο)πιπεριδινης, ως αναστολεις επαναπροσληψεως σεροτονινης
EA200600621A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
HK1068622A1 (en) Novel heteroaryl derivatives, their preparation and use
ATE548353T1 (de) Verfahren zur herstellung von substituierte n- aryl-n'-ä3-(1h-pyrazol-5-yl)phenylü-harnstoffe and intermediate davon.
EA200801081A1 (ru) Способы лечения расстройств центральной нервной системы комбинацией малых доз эсциталопрама и бупропиона
EA200600860A1 (ru) Производные n-тиазол-2-илбензамида
EA200400104A1 (ru) Новые производные индола
EA200501579A1 (ru) Производные 4-(2-фенилсульфанилфенил)-1,2,3,6-тетрагидропиридина в качестве ингибиторов повторного поглощения серотонина
EA200301224A1 (ru) Способ получения имипенема
EA200300179A1 (ru) Производные индола для лечения заболеваний цнс
EA200300084A1 (ru) Производные индола, пригодные для лечения расстройств цнс

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY RU